Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 14 September, the Old Road Campus joined the 2019 Oxford Open Doors event and welcomed the public into our workplace.

The Old Road Campus is tucked out of the way next to the Churchill Hospital, but it’s home to a lot of really exciting medical research. The Department of Oncology, the Ludwig Cancer Research Institute, the Wellcome Centre for Human Genetics, the Structural Genomics Consortium, the Board Game Group, Oxford Universities Hospital Trust, the Biomedical Research Centre, the Nuffield Department for Population Health, and the Jenner Institute all came together to make the Old Road Campus accessible to anyone who wanted to explore.

Oncology was there to highlight how important clinical trials are to our work.  It’s so important to make sure that our ideas are backed by good data. Often new therapies work for only a subset of patients, making it especially important to design our trials to test the research with the right group of patients.

We were delighted to welcome over 180 visitors during the four hours we were open.  Adults and children discovered medical research through interactive exhibits and conversations with our scientists, many visitors also explored our labs guided by the researchers who work there. People came from across Oxfordshire, and we were really pleased to welcome so many of our neighbours from Headington and Cowley.

Our visitors typically spend an hour with us. Strengthened no doubt by tea and cake – which raised over £100 for the Churchill Partners.  https://www.cancerresearchuk.org/content/churchill-partners

Open Doors began life in 2007; a small project of the Oxford Preservation Trust - www.oxfordpreservation.org.uk.  It’s grown from small beginnings to over 30,000 visitors in 2018. A chance for everyone from Oxfordshire to explore the history and work of Oxford. You can read about the growth of Open Doors in this blog by the Oxford Preservation Trust Director -  https://www.oxfordpreservation.org.uk/content/august-oxford-open-doors-your-invitation-explore-city

If you missed Open Doors this year, keep an eye open for next year’s event.

Similar stories

New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.

Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

Machine Learning Enhances Detection of Multiple Cancer Types from Blood

Researchers from the University of Oxford have developed TriOx, a highly sensitive blood test that detects six cancers at their earliest stages. Published today in Nature Communications, the findings highlight the test’s potential to transform early cancer detection and improve patient outcomes.

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Ground-breaking Study reveals previously unknown genetic causes of Colorectal Cancer

A pioneering study, led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC).

Subashan Vadibeler wins 2024 Lasker Essay Contest

Subashan Vadibeler, a recent Oxford Rhodes scholar and Department of Oncology student, is one of five co-winners of the international 2024 Lasker Essay Contest, sponsored by the Lasker Foundation.